IL6 and ovarian cancer: Numerous studies analysing molecular mechanisms of platinum resistance in ovarian cancer have reported that the over-expression of IL-6 is one of the contributing factors for chemo-resistance and poor prognosis via STAT3-mediated activation [34,35].